loadpatents
name:-0.034029006958008
name:-0.0071930885314941
name:-0.049598932266235
Shoshan-Barmatz; Varda Patent Filings

Shoshan-Barmatz; Varda

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shoshan-Barmatz; Varda.The latest application filed is for "empty porous particles for use in treatment, prevention and/or postponement of degeneration of neurodegenerative diseases, neurons and glia".

Company Profile
11.16.27
  • Shoshan-Barmatz; Varda - Omer IL
  • Shoshan-Barmatz; Varda - Dvira IL
  • SHOSHAN-BARMATZ; Varda - Orner IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Biomarkers for diagnosis of lung cancer
Grant 11,408,887 - Shoshan-Barmatz August 9, 2
2022-08-09
Empty Porous Particles For Use In Treatment, Prevention And/or Postponement Of Degeneration Of Neurodegenerative Diseases, Neurons And Glia
App 20220202716 - Feiler; Adam ;   et al.
2022-06-30
Biomarkers Of Chronic Lymphocytic Leukemia And Use Thereof
App 20220170114 - SHOSHAN-BARMATZ; Varda
2022-06-02
Biomarkers of chronic lymphocytic leukemia and use thereof
Grant 11,286,533 - Shoshan-Barmatz March 29, 2
2022-03-29
Means And Methods For Reducing Tumorigenicity Of Cancer Stem Cells
App 20220056456 - SHOSHAN-BARMATZ; Varda
2022-02-24
Vdac Inhibitors For Treating Autoimmune Diseases
App 20220023381 - SHOSHAN-BARMATZ; Varda ;   et al.
2022-01-27
Vdac Inhibitors For Treating Inflammatory Bowel Diseases
App 20220023382 - SHOSHAN-BARMATZ; Varda
2022-01-27
Vdac1 Silencing Molecules And Use Thereof
App 20210395752 - SHOSHAN-BARMATZ; Varda
2021-12-23
Means and methods for reducing tumorigenicity of cancer stem cells
Grant 11,174,484 - Shoshan-Barmatz November 16, 2
2021-11-16
Smac/diablo Inhibitors Useful For Treating Cancer
App 20210261965 - SHOSHAN-BARMATZ; Varda ;   et al.
2021-08-26
Methods For Treating Diabetes Using Vdac1 Inhibitors
App 20210130291 - SALEHI; Albert ;   et al.
2021-05-06
ANALOGUES OF VDAC1-DERlVED PEPTIDES
App 20210079052 - SHOSHAN-BARMATZ; Varda
2021-03-18
Methods for treating central nervous system disorders using vdac inhibitors
Grant 10,946,013 - Shoshan-Barmatz , et al. March 16, 2
2021-03-16
Novel Piperazine And Piperidine Derivatives, Their Synthesis And Use Thereof In Inhibiting Vdac Oligomerization, Apoptosis And Mitochondria Dysfunction
App 20210040047 - SHOSHAN-BARMATZ; Varda ;   et al.
2021-02-11
Analogues of VDAC1-derived peptides
Grant 10,829,530 - Shoshan-Barmatz November 10, 2
2020-11-10
Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction
Grant 10,787,423 - Shoshan-Barmatz , et al. September 29, 2
2020-09-29
Biomarkers Of Chronic Lymphocytic Leukemia And Use Thereof
App 20200270701 - SHOSHAN-BARMATZ; Varda
2020-08-27
Biomarkers For Diagnosis Of Lung Cancer
App 20200173998 - SHOSHAN-BARMATZ; Varda
2020-06-04
Novel Piperazine And Piperidine Derivatives, Their Synthesis And Use Thereof In Inhibiting Vdac Oligomerization, Apoptosis And M
App 20200115348 - SHOSHAN-BARMATZ; Varda ;   et al.
2020-04-16
Methods For Treating Central Nervous System Disorders Using Vdac Inhibitors
App 20200000801 - SHOSHAN-BARMATZ; Varda ;   et al.
2020-01-02
Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction
Grant 10,508,091 - Shoshan-Barmatz , et al. Dec
2019-12-17
ANALOGUES OF VDAC1-DERlVED PEPTIDES
App 20190375808 - Shoshan-Barmatz; Varda
2019-12-12
Methods for treating central nervous system disorders using VDAC inhibitors
Grant 10,434,099 - Shoshan-Barmatz , et al. O
2019-10-08
Analogues of VDAC1-derived peptides
Grant 10,385,104 - Shoshan-Barmatz A
2019-08-20
Means And Methods For Reducing Tumorigenicity Of Cancer Stem Cells
App 20180327753 - SHOSHAN-BARMATZ; Varda
2018-11-15
ANALOGUES OF VDAC1-DERlVED PEPTIDES
App 20180134760 - SHOSHAN-BARMATZ; Varda
2018-05-17
Novel Piperazine And Piperidine Derivatives, Their Synthesis And Use Thereof In Inhibiting Vdac Oligomerization, Apoptosis And Mitochondria Dysfunction
App 20180118700 - SHOSHAN-BARMATZ; Varda ;   et al.
2018-05-03
Methods for Treating Central Nervous System Disorders Using VDAC Inhibitors
App 20180078548 - SHOSHAN-BARMATZ; Varda ;   et al.
2018-03-22
Short peptides derived from VDAC1, compositions and methods of use thereof
Grant 9,758,559 - Shoshan-Barmatz September 12, 2
2017-09-12
Short Peptides Derived From Vdac1, Compositions And Methods Of Use Thereof
App 20160176937 - SHOSHAN-BARMATZ; Varda
2016-06-23
Methods For Diagnosing Cancer
App 20140186837 - Shoshan-Barmatz; Varda
2014-07-03
VDAC1 compositions and methods of use thereof for regulating apoptosis
Grant 8,648,045 - Shoshan-Barmatz , et al. February 11, 2
2014-02-11
N-terminal VDAC variants and uses thereof
Grant 8,440,788 - Shoshan-Barmatz , et al. May 14, 2
2013-05-14
Vdac1 Compositions And Methods Of Use Thereof For Regulating Apoptosis
App 20120214741 - Shoshan-Barmatz; Varda ;   et al.
2012-08-23
Compositions For Silencing The Expression Of Vdac1 And Uses Thereof
App 20120164730 - Shoshan-Barmatz; Varda ;   et al.
2012-06-28
Voltage dependent anion channel (VDAC1) compositions and methods of use thereof for regulating apoptosis
Grant 8,119,601 - Shoshan-Barmatz , et al. February 21, 2
2012-02-21
Compositions for silencing the expression of VDAC1 and uses thereof
Grant 8,093,369 - Shoshan-Barmatz , et al. January 10, 2
2012-01-10
Fluorescent Ruthenium Compounds For Detecting Calcium Binding Proteins
App 20100092995 - Shoshan-Barmatz; Varda ;   et al.
2010-04-15
N-terminal Vdac Variants And Uses Thereof
App 20100075898 - Shoshan-Barmatz; Varda ;   et al.
2010-03-25
Voltage Dependent Anion Channel (Vdac1) Compositions and Methods of Use Thereof for Regulating Apoptosis
App 20080274962 - Shoshan-Barmatz; Varda ;   et al.
2008-11-06
Compositions for Silencing the Expression of Vdac1 and Uses Thereof
App 20080267931 - Shoshan-Barmatz; Varda ;   et al.
2008-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed